PharmaCielo Ltd.
PCLO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 2.53M | 1.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 2.53M | 1.90M |
| Cost of Revenue | -- | -- | -- | 2.01M | 1.89M |
| Gross Profit | -- | -- | -- | 522.70K | 18.30K |
| SG&A Expenses | -- | -- | -- | 3.96M | 4.18M |
| Depreciation & Amortization | -- | -- | -- | 156.40K | 187.00K |
| Other Operating Expenses | -- | -- | -- | -170.40K | -51.10K |
| Total Operating Expenses | -- | -- | -- | 5.95M | 6.20M |
| Operating Income | -- | -- | -- | -3.42M | -4.30M |
| Income Before Tax | -- | -- | -- | -6.69M | -10.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -6.69 | -10.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -6.69M | -10.31M |
| EBIT | -- | -- | -- | -3.42M | -4.30M |
| EBITDA | -- | -- | -- | -2.71M | -3.71M |
| EPS Basic | -- | -- | -- | -0.04 | -0.06 |
| Normalized Basic EPS | -- | -- | -- | -0.02 | -0.03 |
| EPS Diluted | -- | -- | -- | -0.04 | -0.06 |
| Normalized Diluted EPS | -- | -- | -- | -0.02 | -0.03 |
| Average Basic Shares Outstanding | -- | -- | -- | 684.06M | 667.32M |
| Average Diluted Shares Outstanding | -- | -- | -- | 684.06M | 667.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |